Cohance Lifesciences Ltd share price logo

Cohance Lifesciences Ltd Share Price

NSE: COHANCE

BSE: 543064

Mid Cap

Healthcare Sector

₹985.40

+5.00

(+0.51%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Cohance Lifesciences Ltd Stock Performance

as on September 15, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹971.2
    ₹993.65
    downward going graph

    1.44%

    Downside

    0.84%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹856.3
    ₹1,360
    downward going graph

    13.10%

    Downside

    38.02%

    Upside

    downward going graph

Cohance Lifesciences Ltd share price movements today

Previous Close
₹980.40
Open
₹976.95
Volume
91.99K
Upper Circuit
₹1,176.45
Lower Circuit
₹784.35
Day's Low - High
₹971.2 - ₹993.65
52 Week Low - High
₹856.3 - ₹1,360

Cohance Lifesciences Ltd Historical Returns

1 Month Return
+ 9.26 %
3 Month Return
-1.32 %
1 Year Return
-16.75 %
3 Year Return
+ 104.36 %
5 Year Return
+ 156.26 %

Cohance Lifesciences Ltd Fundamentals

as on September 15, 2025 at 4:01 pm IST

Market Cap

₹37,506.88 Cr

Return on Equity (ROE)

12.51

PE Ratio (TTM)

89.7

Return on capital employed (ROCE)

15.94

Industry PE ratio

42.64

Beta (LTM)

0.55

P/B Ratio

12.75

Dividend Yield

0

PEG Ratio

47.71

Quarterly Earnings Growth YOY

-38.44

EPS (TTM)

10.4

Sector

Pharmaceuticals

Book Value

66.64

Technical Analysis

Bullish

View Technical Analysis

Cohance Lifesciences Ltd Stock Valuation

as on September 15, 2025 at 4:01 pm IST

Cohance Lifesciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (4.48x)

March 30, 2020

Industry (42.64x)

September 12, 2025

Today (89.70x)

September 12, 2025

Highest (145.81x)

November 5, 2024

LowHigh

Today’s Price to Earnings Ratio: 89.70x

Cohance Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cohance Lifesciences Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY37,506.8831.25%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY17,878.2412.4%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA4,643.90-3.98%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,855.0644.98%0.672441,515
Poly Medicure Ltd image
Poly Medicure Ltd
HOLD20,490.0961.18%0.533381,669
See all

Analyst Recommendation on Cohance Lifesciences Ltd Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Cohance Lifesciences Ltd. Average target price of ₹1212.86

Source: S&P Global Market Intelligence

Cohance Lifesciences Ltd Share Price Target

Get share price movements and forecasts by analysts on Cohance Lifesciences Ltd.

What analysts predicted

23.71%UPSIDE

Target Price

₹1212.86

Current Price

₹985.4

Analyzed by

7 Analysts

High

₹1500

Target

₹1212.86

Low

₹1055

Cohance Lifesciences Ltd target price ₹1212.86, a slight upside of 23.71% compared to current price of ₹985.4. According to 7 analysts rating.

Source: S&P Global Market Intelligence

Cohance Lifesciences Ltd Stock's Interest Amongst Investors

Investment in Cohance Lifesciences Ltd Shares on INDmoney has grown by 81.57% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:81.57% versus previous 30 day period

Search interest for Cohance Lifesciences Ltd Stock has increased by 166% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:166% versus previous 30 day period

Cohance Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
278.4
353.77
369.36
347.55
231.05
219.82
252.93
488.08
257.72
307.15
840.42
549.31
Other Income
10.92
13.01
11.4
10.67
19.84
14.34
17.05
19.41
14.12
15.71
12.05
14.17
Total Income
289.32
366.78
380.76
358.22
250.9
234.16
269.98
507.49
271.84
322.86
852.47
563.48
Expenses
178.52
207.08
197.49
180.58
133.09
153.74
179.59
362.98
153.71
189.45
626.98
445.4
Operating Profit
99.88
146.69
171.87
166.97
97.96
66.08
73.34
125.1
104.01
117.7
213.44
103.91
Operating Profit Margin %
35.88%
41.46%
46.53%
48.04%
42.4%
30.06%
29%
25.63%
40.36%
38.32%
25.4%
18.92%
Profit Before Interest, Tax and Depreciation
110.8
159.71
183.26
177.63
117.8
80.42
90.4
144.51
118.13
133.41
225.49
118.08
Interest
0.29
1.38
5.03
1.15
0.5
2.16
2.3
10.2
1.67
3.33
10.45
10.18
Depreciation
12.03
12.24
12.02
12.54
11.89
12.79
17.25
31.28
16.96
20.35
54.17
45.14
Profit Before Tax
98.48
146.09
166.21
163.94
105.41
65.47
70.85
103.03
99.5
109.73
160.87
62.76
Tax Paid
26.42
38.37
42.24
43.35
25.84
18.72
17.48
27.66
17.52
26.44
43.72
16.36
Profit After Tax
72.06
107.72
123.97
120.59
79.56
46.75
53.37
75.37
81.98
83.29
117.15
46.4
Total Net profit including share of profit / Loss from associate company
72.06
107.72
123.97
120.59
79.56
46.75
53.37
75.37
81.98
83.29
117.15
46.4
EPS
2.83
4.23
4.87
4.74
3.13
1.84
2.1
1.98
3.23
3.26
3.16
1.28
Actual EPS
2.83
4.23
4.87
4.74
3.13
1.84
2.1
1.98
3.23
3.26
3.16
1.28
Adjusted EPS
2.83
4.23
4.87
4.74
3.13
1.84
2.1
1.98
3.23
3.26
3.16
1.28
Diluted EPS
2.83
4.23
4.87
4.74
3.13
1.84
2.1
1.97
3.23
3.23
3.1
1.27

Cohance Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
377.83
833.79
1,009.72
1,320.22
1,340.33
1,051.35
2,608.5
Other Income
0.6
66.33
67.97
133.49
46.36
61.91
69.21
Total Income
378.43
900.12
1,077.69
1,453.71
1,386.69
1,113.26
2,677.71
Expenses
206.28
452.19
569.24
740.8
766.17
645.54
1,827.22
Operating Profit
171.55
381.6
440.48
579.42
574.16
405.81
781.28
Operating Profit Margin %
45.4%
45.77%
43.62%
43.89%
42.84%
38.6%
29.95%
Profit Before Interest, Tax and Depreciation
172.15
447.93
508.45
712.92
620.53
467.72
850.49
Interest
2.79
19.92
9.14
6.23
12.81
7.45
41.06
Depreciation
11.5
23.51
31.64
39.1
47.99
54.6
166.8
Profit Before Tax
157.86
404.5
467.67
667.59
559.73
405.67
642.63
Tax Paid
48.59
87.51
105.34
213.78
148.44
105.39
158.39
Profit After Tax
109.27
317
362.34
453.8
411.29
300.28
484.24
Total Net profit including share of profit / Loss from associate company
109.27
317
362.34
453.8
411.29
300.28
484.24
EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.79
Actual EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.79
Adjusted EPS
4.3
12.46
14.23
17.83
16.16
11.8
12.79
Diluted EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.68

Cohance Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
50.4
406.92
382.55
330
457.2
358.48
Cash Flow from Investing Activities
-65.48
-413.46
-311.41
-136.14
-195.01
-362.26
Cash Flow from Financing Activities
25.97
7.33
-75.67
-156.48
-241.96
-13.8
Net Cash Flow
10.9
0.79
-4.51
37.38
20.24
-17.57

Cohance Lifesciences Ltd Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
May 2025
Jun 2025
Promoters
60%
60%
60%
60%
60%
60%
50.1%
50.1%
50.1%
50.1%
50.1%
66.41%
66.41%
DII
10.52%
11.35%
11.43%
9.23%
14.14%
15.94%
17.24%
17.42%
16.94%
16.68%
16.6%
11.02%
11.4%
FII
0%
0%
0%
0%
10.01%
10.14%
9.54%
9.8%
10.7%
10.84%
11.05%
7.38%
7.23%
Government
0%
0%
0%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
21.55%
20.53%
19.1%
19.87%
15.84%
13.91%
23.1%
22.67%
22.25%
22.37%
22.23%
15.18%
14.95%
Total Outstanding Shares
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
38,25,67,140
38,25,67,140
Total Shareholders
82,577
79,412
72,885
72,167
73,715
70,052
68,932
65,777
69,337
84,210
86,325
88,658
80,910

Mutual Funds that own Cohance Lifesciences Ltd Stock

Check out the Mutual Funds with significant holdings in Cohance Lifesciences Ltd.

Cohance Lifesciences Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Cohance Lifesciences Ltd.

  • Cohance Lifesciences Ltd Earnings Results

    Cohance Lifesciences Ltd’s net profit fell -35.15% since last year same period to ₹48.88Cr in the Q1 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -59.41% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Cohance Lifesciences Ltd Dividends September,2022

    In the quarter ending June 2022, Cohance Lifesciences Ltd has declared dividend of ₹1.00 per share on 02 Sep 2022 - translating a dividend yield of 1.12%.

    Read More about Dividends

Indices Featuring Cohance Lifesciences Ltd Stock

Check stock indices that include Cohance Lifesciences Ltd.

Nifty MidSmallcap 400

₹20,083.95

0.5 (▲99.1%)

S&P BSE SmallCap Select

₹8,089.80

0.51 (▲41.15%)

Nifty Smallcap 250

₹17,254.25

0.64 (▲109.4%)

S&P BSE 400 MidSmallCap

₹12,171.18

0.46 (▲55.95%)

S&P BSE 250 SmallCap

₹6,904.69

0.61 (▲41.7%)

BSE Healthcare

₹44,718.48

-0.45 (▲-204.09%)

Nifty 500

₹23,215.85

0.11 (▲25.6%)

Nifty MNC

₹30,295.40

0.17 (▲49.95%)

BSE 500

₹36,452.98

0.09 (▲34.36%)

BSE Small-Cap

₹53,903.19

0.66 (▲354.7%)

Insights on Cohance Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 8.65% to 8.90% in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.8% return, outperforming this stock by 33.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.41% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 10.0% return, outperforming this stock by 26.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 15.18% to 14.95% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.38% to 7.23% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, COHANCE stock has moved down by -3.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 120.43 Cr → 48.88 Cr (in ₹), with an average decrease of 59.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 852.47 Cr → 563.48 Cr (in ₹), with an average decrease of 33.9% per quarter

About Cohance Lifesciences Ltd

Suven Pharmaceuticals Limited (SPL) is a biopharmaceutical company engaged in the development and manufacturing of New Chemical Entity (NCE) based Intermediates and Active Pharmaceutical Ingredients, Speciality Chemicals, and formulated drugs. In 2019, Suven Life Sciences Ltd. transferred the CRAMS business to the Company, and the equity shares of the Company were listed for trading in March 2020. The Board approved and recommended the issue of 1:1 bonus shares in August 2020, and the number of shares increased from 127,282,478 to 254,564,956. In 2021, Suven invested 120 crore in investing and has a capex plan of Rs.320crore. In 2022, the Company also filed 17 ANDAs for which 9 were approved and 8 products were launched. The Company acquired 100 stake in Casper Pharma Private Limited in 2022, making it a Wholly Owned Subsidiary. In this way, Suven Pharmaceuticals Limited is endeavouring to be the leading biopharmaceutical company in global markets.

Revenue: ₹549.31Cr as on June 2025 (Q1 FY26)
Net Profit: ₹46.40Cr as on June 2025 (Q1 FY26)
Listing date: 05 Mar, 2020
Chairperson Name: Annaswamy Vaidheesh
OrganisationCohance Lifesciences Ltd
IndustryPharmaceuticals
CEOAnnaswamy Vaidheesh
E-voting on sharesClick here to vote

FAQs

What is Cohance Lifesciences Ltd share price today?

Cohance Lifesciences Ltd share price today stands at ₹985.4 as on at the close of the market. Cohance Lifesciences Ltd share today touched a day high of ₹993.65 and a low of ₹971.2.

What is the 52 week high and 52 week low range for Cohance Lifesciences Ltd share?

Cohance Lifesciences Ltd touched a 52 week high of ₹1360 and a 52 week low of ₹856.3. Cohance Lifesciences Ltd share price today i.e. is closed at ₹985.4, which is -27.54% down from its 52 week high and 15.08% up from its 52 week low.

What is Cohance Lifesciences Ltd's market capitalisation today?

Cohance Lifesciences Ltd market capitalisation is ₹37,506.88 Cr as on .

How to buy Cohance Lifesciences Ltd shares?

To buy Cohance Lifesciences Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for COHANCE or Cohance Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Cohance Lifesciences Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Cohance Lifesciences Ltd trading volume today?

Cohance Lifesciences Ltd trading volume is 91.99K as on . This means that 91.99K shares of Cohance Lifesciences Ltd were bought and sold on the stock market during today's trading session.